Trial · NCT01890915
Body Temperature in Persons With Tetraplegia When Exposed to Heat
NCT01890915, Completed, James J. Peters Veterans Affairs Medical Center; results first posted 2016-03-03
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Body Temperature in Persons With Tetraplegia When Exposed to Heat. Trials, record NCT01890915. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01890915
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Body Temperature in Persons With Tetraplegia When Exposed to Heat
- NCT number
- NCT01890915
- Status
- Completed
- Enrollment
- 21 participants, actual
- Lead sponsor
- James J. Peters Veterans Affairs Medical Center
- Conditions
- Spinal Cord Injury
- Interventions
- Heat Exposure
- First posted
- 2013-07-02
- Last updated
- 2016-03-03
- Results first posted
- 2016-03-03
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Core Body Temperature | 2 hours | To determine the change in core body temperature in the seated position from 79 degrees F for 30 minutes to 95 degrees F for up to 2 hours. Hypotheses: Persons with tetraplegia will have a greater increase in core body temperature than able-bodied (AB) control subjects. Core body temperature in AB persons will be maintained. |
| Secondary | Cognitive Performance - Stroop Interference T-Scores | 2 hours | To determine the change in cognitive performance as measured by the Stroop Color and Word Interference T-Scores, measured after 30 min at 79 degrees F and after up to 2 hours at 95 degrees F. Interference T-Scores are derived from the difference between the raw Color-Word score and the projected Color-Word score (which is, in turn, based on the raw scores obtained in the Word and Color portions of the Test). Lower scores indicate poorer performance, and a positive percent change in T-scores indicates improved performance. Hypothesis: Persons with tetraplegia compared with AB will have a greater change in cognitive performance from baseline (79 degrees) to warm exposure (95 degrees). |
| Other | Sweat Rate | 2 hours | To determine the change in sweat rate using QSweat methodology (WR TestWorks) from 30 minutes at 79 degrees F compared to after up to 2 hours at 95 degrees F. Sweat collection capsules will be placed on the left lateral anterior shoulder, volar aspect of the distal forearm, proximal anterior thigh, and mid-lateral calf (dermatomes C5, T1, L3, L5) for measurement of sweat rate. Hypothesis: Persons with tetraplegia compared with AB will have less of a percent change in average sweat rate after heat exposure. |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Core Body Temperature | 2 hours | Percent Change | MEAN | |
| SECONDARY | Cognitive Performance - Stroop Interference T-Scores | 2 hours | Percent change | MEAN | |
| OTHER_PRE_SPECIFIED | Sweat Rate | 2 hours | Percent change | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Core Body Temperature | Tetraplegia | 2.04 | Standard Deviation 0.49 | Percent Change | |
| Core Body Temperature | Control | -0.05 | Standard Deviation 0.61 | Percent Change | |
| Cognitive Performance - Stroop Interference T-Scores | Tetraplegia | 8.3 | Standard Deviation 5.9 | Percent change | |
| Cognitive Performance - Stroop Interference T-Scores | Control | 0.3 | Standard Deviation 6.6 | Percent change | |
| Sweat Rate | Tetraplegia | 51.4 | Standard Deviation 12.6 | Percent change | |
| Sweat Rate | Control | 1030.2 | Standard Deviation 654.9 | Percent change |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Tetraplegia | 11 | |
| Overall Study | STARTED | Control | 10 | |
| Overall Study | COMPLETED | Tetraplegia | 8 | |
| Overall Study | COMPLETED | Control | 9 | |
| Overall Study | NOT COMPLETED | Tetraplegia | 3 | |
| Overall Study | NOT COMPLETED | Control | 1 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Autonomic dysreflexia | Nervous system disorders | Tetraplegia | 1 | 11 | 1 |
| serious | Autonomic dysreflexia | Nervous system disorders | Control | 0 | 10 | 0 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Tetraplegia | ||
| Total, all-cause mortality | Control | ||
| Total, other adverse events | Tetraplegia | 0 | 11 |
| Total, other adverse events | Control | 0 | 10 |
| Total, serious adverse events | Tetraplegia | 1 | 11 |
| Total, serious adverse events | Control | 0 | 10 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Tetraplegia vs Control: serious adverse events |
Source Trial comparisons
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01890915
GET https://conductscience.org/api/trials/v1/NCT01890915/registered